Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06546410
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-06
Brief Title:
OASIS RetrOspective Analysis on EEGs for Identifying Seizure Susceptibility in paediatrIcs Using biomarkerS
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Retrospective Multisite Analysis of Routinely Collected Outpatient EEGs for Identifying Seizure Susceptibility in Paediatric Epilepsy Using Computational Biomarkers
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
OASIS
Brief Summary:
The goal of this retrospective study is to validate a set of computational biomarkers BioEP for seizure susceptibility on retrospective routinely collected non-contributory EEGs in paediatric participants with epilepsy The main objectives are
Primary
To validate a set of computational biomarkers BioEP for seizure susceptibility on retrospective routinely collected non-contributory EEGs in paediatric participants with epilepsy
Secondary
To examine whether the use of BioEP could support a more efficient patient pathway to diagnosis thus adding economic value by reducing time to final diagnosis andor the number of clinical appointments needed
Primary
To validate a set of computational biomarkers BioEP for seizure susceptibility on retrospective routinely collected non-contributory EEGs in paediatric participants with epilepsy
Secondary
To examine whether the use of BioEP could support a more efficient patient pathway to diagnosis thus adding economic value by reducing time to final diagnosis andor the number of clinical appointments needed
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None